John Young is an accomplished board member with extensive experience in the pharmaceutical and healthcare industries. Currently serving as a board member for Novartis since March 2023, Arvinas since August 2022, and Johnson Controls since December 2017, Young has a strong focus on advancing health and technology. Previous board membership includes Imbria Pharmaceuticals from March 2022 to July 2024 and Haleon from July 2022 to March 2023. Notably, Young held a long tenure at Pfizer from September 1987 to July 2022, culminating in roles such as Special Advisor to the CEO and Group President. Educational credentials include a B.Sc in Biology from the University of Glasgow and an MBA from the University of Strathclyde.
This person is not in the org chart
This person is not in any offices